Tags : Vaccine Candidate

Pharma Regulatory

Sinovac Initiates the P-I Clinical Study for Vaccine Candidate Against

Shots The company has commenced P-I clinical study assessing its vaccine candidate vs PBO in 144 healthy adults, aged 18-59yrs, with two different dosages of the vaccine candidate, conducted in Jiangsu Province The study evaluates the safety, tolerance, and preliminary immunogenicity of Sinovac’s SARS-CoV-2 vaccine under which two-thirds of the volunteers will be vaccinated with […]Read More